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 Identiﬁcation of two new polymorphs
of benznidazole.
 The polymorphism of benznidazole
was conﬁrmed by four experimental
techniques.
 The thermodynamic relationships
among these polymorphs were
discussed.
 The aqueous solubility of the three
polymorphs was determined.
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a b s t r a c t
Benznidazole (N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide), is a nitro-heterocyclic drug used in the
treatment of Chagas disease. Despite the fact that this drug was released more than 30 years ago, little
information about its solid state properties is available in the literature. In this study, it was veriﬁed that
this drug exhibits three polymorphs, which were characterized in situ by X-ray powder diffraction, ther-
mal analysis, hot stage microscopy and infrared spectroscopy. The thermodynamic relationships among
these polymorphs were also discussed.
 2013 Elsevier B.V. All rights reserved.
Introduction
Chagas disease, which is caused by the ﬂagellate Trypanosoma
cruzi, is a vector-borne parasitic zoonosis discovered by Carlos Cha-
gas in 1909. Despite recent advances in the control of its vectorial
and transfusional transmission, it remains the major parasitic
disease burden in Latin America. It is estimated that 90 million
people are at risk of contracting Chagas disease and more than
eight million are infected in 18 endemic countries [1].
Many attempts to develop a treatment for Chagas disease have
been made during the last century [2]. However, the pharmacolog-
ical treatment of the T. cruzi infection has varied little over the last
40 years. The currently available drugs are nifurtimox, released in
1967 by Bayer (Lampit), and benznidazole, released in 1972 by
Roche (Rochagan or Radanil). Good results have been achieved
using these drugs in the acute phase, congenital infection and lab-
oratory accidents, but variability in efﬁcacy may occur for chronic
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infections. The use of benznidazole in a parasitological therapy
during the chronic phase is still under investigation [3]. At the best
of our knowledge, there are no alternative drugs against Chagas
disease in clinical development [4].
Benznidazole (BZN, (N-benzyl-2-(2-nitro-1H-imidazol-1-
yl)acetamide, Fig. 1) is better tolerated than nifurtimox and it is fa-
vored by most experts as the ﬁrst-line treatment for Chagas dis-
ease. As stated, BZN was originally developed by Roche, but since
2003 the license and rights of the drug were transferred to the
pharmaceutical laboratory of the Brazilian state of Pernambuco
(LAFEPE). Thus, new developments are required in order to ensure
the continuous synthesis and production of this drug. Despite the
fact that BZN has been applied to the treatment of Chagas disease
for a long time, there is scarce information about its physicochem-
ical properties. Recent investigations have reported the crystalline
structure and physicochemical characterization of BZN [4–8].
However, all these reports support the hypothesis that BZN does
not exhibit polymorphism. In view of the relevance of this drug
for the Latin American public health programs and the urgent need
to improve the synthesis and formulation processes, the aim of this
study is to explore carefully the polymorphism of BZN using sev-
eral experimental techniques.
Experimental section
Crystal growth
The raw material of BZN used in the crystallization essays was
supplied by Oswaldo Cruz Foundation (FioCruz, Institute of Drug
Technology-FarManguinhos). The solubility of BZN in several sol-
vents at room temperature was investigated by Maximiano et al.
[5]. Following these results, BZN crystals (Form I) were grown by
the slow evaporation method using acetone, ethyl acetate and eth-
anol as solvents at 5 C and 20 C. The best crystals were obtained
at low temperature using ethanol. BZN crystals grow with a nee-
dle-like habit in a radiating manner. Form III was produced based
on the hot-stage microscopy and DSC observations (see below for a
detailed description) by rapid quenching, placing the melted sam-
ple (200 C) on a metallic surface at room temperature. The resid-
ual amorphous phase was transformed into Form III by heating
gently up to 50 C. Form II was obtained by heating Form III up
to 150 C.
X-ray diffraction
Data collection of selected BZN crystals was performed at room
temperature and at 150 K. All X-ray diffraction intensities were
collected using an Enraf–Nonius Kappa-CCD diffractometer (graph-
ite monochromated Mo Ka X-ray beamwith k = 0.71073 Å,u scans
and x scans with j offsets, 95 mm CCD detector on a j-goniostat),
equipped with a cold N2 gas blower cryogenic apparatus (Bruker,
Ettlingen, Germany). Details of the data processing, solving and
reﬁnement can be found elsewhere [9]. The crystallographic infor-
mation ﬁles (CIF ﬁles), containing all crystal data of the BZN struc-
ture determination, were deposited with the Cambridge Structural
Data Base under deposition codes CCDC 812245 and 812246.
Copies of these ﬁles may be solicited free of charge from The
Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK,
fax: +44 123 336 033; e-mail: deposit@ccdc.cam.ac.uk or http://
www.ccdc.cam.ac.uk.
Conventional X-ray powder diffraction proﬁles of the samples
were also recorded using a D8 Advance X-ray powder diffraction
system (Bruker, Ettlingen, Germany) working in the Bragg–Brent-
ano geometry and equipped with a Göbel mirror and a LynxEye
detector. Patterns were collected from laboratory temperature
(about 25 C) up to 200 C in nitrogen atmosphere, using Cu Ka
radiation, operated at 40 kV and 25 mA.
Thermal analysis
DSC thermograms of heating/cooling cycles were recorded in a
Phoenix 204 system (Netzsch, Selb, Germany), using heating (cool-
ing) rates, ranging from 0.1 to 200 oC min1. Hot stage microscopy
(HTM) investigations were registered using a DM2500P polariza-
tion microscope (Leica, Wetzlar, Germany) equipped with a Koﬂer
hot stage. The microphotographs were taken with a digital camera
(Leica EC 3).
Vibrational spectroscopy
Infrared spectra were recorded on a Vertex 70 Fourier Trans-
form Infrared spectrometer (Bruker, Ettlingen, Germany). KBr pel-
lets of solid samples were prepared from mixtures of KBr and the
sample in a 400:1 ratio using a hydraulic press. Attenuated total
reﬂectance and diffuse reﬂectance sampling techniques provided
similar spectra. A liquid-nitrogen cryostat (Janis Research,
Wilmington, USA) was employed to record FT-IR spectra as a func-
tion of temperature. The principal component analysis of the spec-
troscopic data was performed using the Unscrambler MVDA
software (version 9.5, Camo Inc., Woodbridge, New Jersey, U.S.).
Data were preprocessed using Multiple Scatter Correction (MSC).
Fig. 1. Room temperature BZN crystal structure (Form I) showing (a) the intramo-
lecular hydrogen bonds in the asymmetric unit; and (b) the main intermolecular
interactions in the unit cell.
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Solubility determination
The aqueous solubilities of the samples were determined fol-
lowing the procedure described by Lima et al. [10]. The solutions
were then analyzed by determining the UV absorbance for each
sample at 324 nm using a Specord 250 UV/VIS spectrometer (Anal-
ytik Jena, Jena, Germany).
Results and discussion
Single crystal X-ray diffraction
The crystal structure of BZN was recently determined by
Soares-Sobrinho et al. at -173 oC [8]. Nevertheless, in order to con-
ﬁrm the structure at room temperature, which is the relevant for
pharmaceutical applications, and to investigate temperature in-
duced structural changes, we have determined the structures at
room temperature and -123 oC. Both structures belong to the same
space group and little temperature-dependence of the lattice
parameters was observed. These results show only small
conformational changes in the asymmetric unit being the mole-
cules at both temperatures easily superimposed. Thus, one may
assume that no solid–solid phase transition takes place between
-173 oC and 20 oC. High-resolution synchrotron X-ray diffraction
measurement conﬁrms that the raw material crystalizes in the
same structure (see Supplementary material, Fig. S1).
The analysis of the asymmetric unit reveals the presence of two
intramolecular interactions that help stabilizing the molecular
conformation (Fig. 1a). One of them, C11–H11b  O18, involves
the oxygen of the nitro group bonded to the imidazole moiety,
leaving it almost coplanar with the ring, but showing a small twist
of 5.3(3). The other intramolecular interaction, C7–H7b  O10,
helps the planarity of the group involving the atoms C7, N8, C9,
O10 and C11. The analysis of the molecular bond length indicates
a resonance of the acetamide group, relating the N, O and
C atoms with relative distances of O10–C9 = 1.233(3) Å, C9–
N8 = 1.334(3) Å, and O18–N17 = 1.227(4) Å. The angles of the
nitrogen atoms in the main chain are bigger (120) than expected
from sp3 hybridization (109.5), suggesting that the nitrogen has an
sp2 character and that free electron pairs of the nitrogen atoms
form an unallocated p electron system.
The crystal lattice of BZN consists of inﬁnite chains along the
a-axis, stabilized by a bifurcate intermolecular interaction involv-
ing the oxygen atom of the acetamide group (Fig. 1b). These chains
connect planes of BZN molecules parallel to the (102) plane family.
In addition to those interactions, the structure presents three non-
classical intermolecular interactions of C–H  O and C–H  N, con-
necting neighboring chains along the crystallographic axis b and
forming the three-dimensional network.
Fig. 2. Polarized light microphotographs of BZN. (a) Slow evaporation crystallization; (b) nucleation and growth of Form I from the melt under seeding; (c) growth of the
Form III spherulite on quenching; (d) growth of Form III upon heating (50 C); (e) transformation of Form III spherulites into Form II (100 C); and (f) complete conversion to
Form II (160 C).
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Thermal analysis
The thermal stability of BZN was investigated through thermo-
gravimetric measurements showing that BZN is stable up to
approximately 274 C (see Supplementary material, Fig. S2). Since
thermogravimetric measurements showed that BZN does not
decompose on melting, several attempts of recrystallizing it from
the melted sample were performed using HTM and DSC. In Fig. 2,
representative HTM images of the observed crystal habits are pre-
sented. The needle-like habit of the samples crystallized by slow
evaporation can be clearly identiﬁed in Fig. 2a. Since it is also a
characteristic of the raw material and it seems to be the most sta-
ble form, it will be labeled as Form I. Seeding experiments at about
180 C showed a very high crystal growth rate of Form I in the
supercooled melt (Fig. 2b). However, the stable Form I does not
nucleate spontaneously from the melt. By cooling down the melt
without seeding, BZN recrystallizes with a spherulite habit
(Fig. 2c), hereby Form III. Furthermore, no transition from Form
III to Form I was observed on cooling, which indicates that either,
in the case of enantiotropism between these forms, the transfor-
mation is kinetically hampered, or Forms III and I are monotropi-
cally related. If the sample is quenched to room temperature,
some scattered spherulites are observed submersed in the super-
cooled melt, which nucleate spontaneously around 50 C
(Fig. 2d). Above 100 C, a new phase (Form II) starts to grow with
an acicular habit, destroying the spherulites (Fig. 2e). This process
is completed above 130 C (Fig. 2f). Upon heating, Form II melts
around 188 C.
DSC thermograms were recorded in successive heating/cooling
cycles under rates ranging from 0.1 to 200 C min1 showing a con-
sistent behavior whenever the raw material or crystals obtained by
slow evaporation were used as a starting point. The higher temper-
ature was limited to 200 C in order to avoid the decomposition of
BZN (see Supplementary material, Fig. S3). Fig. 3 shows typical
curves of two successive DSC thermograms recorded at 5 C min1.
The main feature of both curves is an endothermic peak character-
istic of the melting process. However, after the second heating, the
melting of BZN is observed at a slightly lower temperature
(188 C). The cooling process is characterized by one or several
sharp exothermic events, which depend on the thermal history of
the sample and are associated to the recrystallization of the scat-
tered spherulites (Form III) from the supercooled melt. A detailed
analysis of the second heating reveals a weak exothermic event
at 105 C (inset of Fig. 2). It is important to point out that after
the ﬁrst melting, successive thermal cycles did not recover the ori-
ginal form (melting point at 190 C), even combining different
heating/cooling rates. On the other hand, after leaving a melted
sample several days at atmospheric conditions, the elusive Form
I was recovered.
The thermodynamic relationship among the polymorphs
(Fig. 4) can be established using the melting points combined with
the heat of fusion (HFR) and heat of transition (HTR) rules stated by
Burger and Ramberger [11,12]. From the HFR, it may be inferred
that the polymorph with higher melting point (Form I) must be
monotropically related to the Form II, since the fusion enthalpy
of the former is higher. Despite the fact that it is not possible to
measure the melting point of Form III, we may conclude that there
is a monotropic relationship between this polymorph and Form II,
since there is an exothermic transformation relating them (HTR).
Therefore, one may expect that the melting point of Form III should
be lower than the one of Form II. The fusion enthalpy of Form III
may be estimated using Hess’s law as the sum of the III? II tran-
sition heat and the heat of fusion of Form II. As a consequence, the
heat of fusion from Form III should be around 105 J/g. The fact that
it has the lowest fusion heat suggests that Form III is the less stable
one and is monotropically related to the other two polymorphs.
Based on these results, the isobaric free energy curves representing
the three polymorphs are shown in Fig. 4.
X-ray powder diffraction
The polymorphs of BZN were also identiﬁed by XRPD measure-
ments. In Fig. 5, the temperature dependence of the X-ray powder
patterns were recorded as a function of the temperature following
a strategy based on the DSC results. First, the raw material (Form I)
was heated up to 200 C under nitrogen atmosphere (Fig. 5a). After
cooling down the melted sample, it was grounded to avoid prefer-
ential orientation and heated again up to 175 C (Fig 5b). Finally, a
third heating/cooling cycle was performed without further sample
processing (Fig. 5c).
As a rule, the powder patterns of the three crystalline forms are
very close, suggesting there are subtle structural differences
among them. Due to that, a small region of the powder pattern
(23–27) will be used in this discussion in order to emphasize
the observed modiﬁcations. By comparing the room temperature
pattern it may be observed that the peak at 23.8 is not affect by
the thermal cycles. This peak is associated to the (102) plane fam-
ily, which separates planes of BZN molecules connected by the
main hydrogen bond interaction (Fig. 1b). On the other hand, the
Fig. 3. DSC thermograms of successive heating/cooling cycle of a recrystallized
sample of BZN (heating: 5 C min1, cooling: 50 C min1). The inset shows a zoom
(50) of the previous thermograms. Curves are vertically shifted for clarity.
Fig. 4. Semi-schematic energy/temperature diagram of BNZ polymorphs. Tf, melt-
ing point; G, Gibbs free energy; H, enthalpy; DHf, enthalpy of fusion; Tt, transition
point; DHt, transition enthalpy; liq, liquid phase (melt). The bold vertical arrows
signify experimentally measured enthalpies.
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peaks between 24.6 and 25.6 exhibit well deﬁned relative inten-
sity variation after the successive thermal cycles. These reﬂections
are related to planes (120), (112) and (031) intercepting the BZN
chains along the b direction. As a consequence, it could be pro-
posed that subtle reorientations of the BZN molecules characterize
the polymorphic transformations, whereas the main intermolecu-
lar pattern is preserved. Based on the thermal analysis results,
the three different powder patterns recorded at room temperature
can be associated with Forms I, III and II, respectively.
Regarding to the temperature dependence of the XRPD patterns,
as expected, the ﬁrst heating (Fig. 5a) does not show any evidence
of structural phase transitions, conﬁrming that Form I is stable up
to the melting point. By comparing the temperature evolution of
Fig. 5b and c, it may be veriﬁed that both present the same pattern
at 175 C, which may be ascribed to Form II. Furthermore, the
transformation from Form III into Form II is depicted around
125 C. It is also important to point out that no changes were ob-
served in the powder pattern recorded after the third heating
(not presented here) showing that Form II does not transform back
into Form III. In good agreement with the thermal analysis results,
XPRD conﬁrms that after melting, Form I recrystallizes in a new
polymorph (Form III), which exhibits an irreversible structural
phase transition around 125 C (Form II).
Vibrational spectroscopy
Vibrational spectroscopy is a powerful tool to investigated
polymorphic transitions in drugs [13,14]. The vibrational spec-
trum of BZN was investigated through Raman scattering, mid-
(MIR) and near-infrared (NIR) spectroscopies (see Supplementary
material, Fig. S4). However, additional conﬁrmation of the struc-
tural phase transformations was obtained by temperature-depen-
dent infrared absorption measurements. IR spectra were recorded
in situ using a liquid nitrogen cryostat, where the sample (in a KBr
pellet) is in vacuum. Two successive heating processes up to
195 C are presented in Fig. 5. Form I is stable up to the melting
point (Fig. 6a), which was observed around 170 C. The lowering
of the melting point, estimated from the FT-IR measurements,
could be induced by the vacuum environment. Infrared spectra
above this temperature correspond to the melted form of BZN.
As observed in the DSC thermograms, the melting point of Form
II (around 165 C) is lower than the one of Form I (Fig. 6b). Subtle
changes in the infrared spectra characterize the solid–solid tran-
sition between Forms III and II. Thus, a traditional data processing
procedure based on uni- or bivariate approaches considering the
positions and/or the intensities of the bands will hardly provide
valuable information. On the other hand, multivariate methods
such as principal component analysis (PCA) and partial least-
squares (PLS) regression combined with methods of spectral
pre-processing have been proven to be suitable to monitor the
temperature evolution [15]. Fig. 6c and d shows the temperature
evolution of the ﬁrst (PC1) and second (PC2) principal compo-
nents calculated from the spectra of the ﬁrst and second heating.
The principal components related to Form I (ﬁrst heating) change
continuously up to the melting point, whereas those calculated
from the spectra of the second heating exhibit different behaviors
depending on the temperature. Thus, the continuous increase of
PC1 during the second heating below 50 C could be associated
with the recrystallization of the Form III from the supercooled
melt (Fig. 2d). This form transforms into Form II around 125 C
as evidenced by the decreasing of PC1, which also changes its
behavior around 165 C, ﬁngerprinting the melting point. Similar
features can be identiﬁed in PC2, showing that infrared absorp-
tion spectroscopy also conﬁrms the polymorphism of BZN. By
comparing the infrared spectra of the three polymorphic forms,
subtle changes in the 1400–1510 cm1 region can be observed.
This spectral region is associated to the d(CH) and d(CH2) angular
deformations. Since these bands are not directly related to the
hydrogen bond pattern, it could be proposed that the polymor-
phic forms are mainly related by molecular reorientation and/or
conformational changes supporting the small modiﬁcations ob-
served in the XRPD patterns.
Solubility
The aqueous solubilities of Forms I [0.22(2) mg/mL], II
[0.24(2) mg/mL] and III [0.25(2) mg/mL] were determined as the
average concentration of several samples. These results agree very
well with the value reported by Maximiano et al. [5] in raw mate-
rials (Form I), showing that the equilibrium solubilities of three
forms are not signiﬁcantly different. FT-IR and XRPD analysis were
performed to identify the undissolved powder after the dissolution
analysis. All these patterns are identical to those of Form I. This ef-
fect can be ascribed to a solvent-mediated transformation of the
Fig. 5. Temperature-dependent X-ray powder diffraction patterns of BZN: (a) ﬁrst, (b) second and (c) third heatings.
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metastable forms (II and III) into the stable phase (Form I) during
the solubility analysis.
Conclusions
Our results show, for the ﬁrst time, that BZN is a polymorphic
compound exhibiting three closely related crystalline forms. Two
new polymorphs were obtained by crystallization from the melted
sample. They are monotropically related to the most stable one
(Form I). The room temperature and 150 K crystalline structures
were determined based on single-crystal X-ray diffraction data,
showing that no structural phase transitions are present below
room temperature. In addition, the aqueous solubility of the three
polymorphs was compared evidencing a solvent-mediated trans-
formation of the metastable forms into the stable most stable one.
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